CREATING VALUE OUT OF

SCIENTIFIC MILESTONES

World class discoveries in bioscience provide the fundamental basis for pharmaceuticals and devices that global populations of patients, hospitals and healthcare providers rely on every day.

Innovations with real world potential to create a disease-free world are becoming more urgent than ever before.

Our experts at The iQ Group Global find, fund and develop life-changing bioscience assets.

With four direct listings on two Australian exchanges and expertise in private banking, financial planning and equities analysis, The iQ Group Global creates opportunities to bring unique innovations to global healthcare markets.

Get in touch, or register below for opportunities.

Partner with us

Unico Lan

Group Director, APAC

Unico Lan

Group Director, APAC

Adv Dip. FP, BCom, MIntBus

With over 15 years’ experience in managing growth in financial markets, Unico has developed excellent relationship management skills with affluent clients, referral partners, investment teams, product teams, treasury and compliance. Unico ensures strong growth and meaningful outcomes – analyzing and identifying risk, as well as ensuring compliance.
 
Prior in joining The iQ Group Global, Unico held senior leadership roles with various highly reputable wealth management organizations both in Australia and China, including within Citibank Australia.
 
One word for iQ – Futurist

Lei Xu

Director, Corporate Finance and Advisory

Lei Xu

Director, Corporate Finance and Advisory

BSc(Acc), MSc(Mgt), FCCA, MBA(Exec)

As Director, Corporate Finance and Advisory, Lei is responsible for structuring the equity investment offerings for capital raising through equity capital markets. Also, Lei works closely with The Group’s capital access and corporate advisory functions to create structured financial instruments for funding the development of novel biotech assets.
 
Lei holds an MBA from AGSM, and is Fellow of the Association of Chartered Certified Accountants. Lei previously served as Director of APAC for The iQ Group Global.

One word to describe iQGG – Intelligence

Alan Wong

Head Private Wealth Relationship Manager, APAC

Alan Wong

Head Private Wealth Relationship Manager, APAC

B.Ec.

With 9 years’ experience in the wealth management sector, particularly in the finance and biotech industry, Alan has developed professional management skills with high net worth clients. Alans’ background in equity, fixed income, hybrid securities, managed and structured investment and foreign exchange markets, gives him the tools to market a number of financial products to current and existing investors.
 
As the Head of Relationship Management in the APAC private wealth team, Alan is responsible for providing investment strategies and solutions to high net worth individuals within the APAC region.

One word to describe iQGG – Breakthrough

Brent Stadus

Chief Investor Relationship Officer, Ethical Bioscience Investments

Brent Stadus

Chief Investor Relationship Officer, Ethical Bioscience Investments

With 15 years’ experience extending across business development and relationship management, Brent Stadus conducts business with an entrepreneurial mindset and work ethic.

As an avid investor in financial markets, Mr. Stadus is particularly passionate about ethical impact investing. He has attained a wealth of experience in managerial roles spanning across industries from financial services and advisory, equities and brokerage to luxury automotive. He additionally has an abundance of knowledge from his experience as a successful business owner and operator in the high-end retail market.

One word to describe iQGG – Ingenious

Samuel Boctor

Private Wealth Relationship Manager, Capital Access

Samuel Boctor

Private Wealth Relationship Manager, Capital Access

B.Com

With eight years’ experience in investor relationship management and financial markets, Samuel is passionate about unique investment tools that add value to investor portfolios. Having previously held an executive role at an asset management firm, Samuel’s knowledge extends across a diverse range of financial products.
 
At The iQ Group Global, Samuel is responsible for connecting and building long-term relationships with qualified investors who are excited about investment opportunities in the biotechnology market.
 
One word to describe iQGG – Novel

Amy Xu

Private Wealth Relationship Manager, APAC

Amy Xu

Private Wealth Relationship Manager, APAC

Amy is an entrepreneur who has a wealth of experience with healthcare product development from concept to shelf, involving managing formulation, manufacturing, regulation, marketing and distribution.
 
Prior to joining, Amy served in public office for four years and has lead a PR consultancy which effectively assists clients with branding and sales via tailored campaigns. Amy also serves honorary positions in a number of business associations and holds a Bachelor of Arts, Media and Culture Studies from Macquarie University.
 
At The iQ Group Global, Amy is responsible for managing capital access within the APAC region and working alongside the APAC Investor Relations Team to develop strategies to enhance the interaction and communication between The Group and the APAC region.

One word to describe iQGG – Disruptive

Ozel Djemal

Investor Engagement Manager

Ozel Djemal

Investor Engagement Manager

At The iQ Group Global, Ozel is responsible for engaging and managing the relationship with potential and existing investors who are looking for new and innovative opportunities in the biotechnology investment market.
 
With 18 years’ experience in relationship management, Ozel is passionate about building long term relationships with individuals and is a dedicated professional focusing on customer engagement and relationship management. Having previously worked in the luxury automotive and technology industries, Ozel’s unique experience has led him to mastering skills in high-end competitive sales and elite management positions.

One word to describe iQGG – Innovative

At The iQ Group Global, we create new paths leading to the edge of human discovery.

Dr. George Syrmalis
Group Chief Executive Officer

CONNECT WITH THE TEAM